High margin · open room capacity
Profit decisions for cosmetic dermatology practices
Know what to promote—and what to stop.
OrcBrain analyzes treatment bookings, payments, discounts, costs, and capacity to show which services deserve more marketing, higher pricing, or fewer promotions.
We work remotely from exports you already have. Your current practice software stays in place.
Demand supports less discounting
Already saturated · shifts full-price demand
Illustrative example—not a promised result.
Same reports. Better decisions.
From “what sold?” to “what makes money next?”
Marketing follows last month’s highest revenue.
Market treatments with strong contribution and room to grow.
Use ad spend where growth is possible.Lower prices whenever bookings need a boost.
Reduce discounts where patients already book at full price.
Keep more margin from existing demand.Strong booking volume makes the campaign look successful.
End promotions that mainly shift full-price bookings.
Avoid paying to replace revenue you already had.The 30-day Aesthetic Profit Review
One location. At least three source-backed profit decisions.
We reconcile the reports, model the financial impact, and deliver a concise owner brief showing what to promote, price differently, or stop promoting.
The guarantee
Useful output—or your pilot fee back.
We inspect sample exports before you pay. If we accept the pilot and—after you provide the agreed files—we cannot deliver at least three source-backed recommendations with modeled financial impact within 30 days, we refund the pilot fee.
Check whether my reports work → This guarantees the agreed analysis—not a specific business result.Three questions
Before the review
What do you need from us?
A sample export or screen-share first. If the reports fit, the review typically uses booking, payment, discount, refund, provider or resource, and basic cost fields.
Is this new software for the team?
No. It is a remote, managed analysis of exports from the systems you already use.
Does the guarantee promise more profit?
No. It guarantees at least three source-backed recommendations with modeled financial impact. Actual results depend on execution and market conditions.
Start without risk
First, we check whether your reports can support the review.
If they cannot, you do not start—and you do not pay.